Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Caplin Point Laboratories Management Change

Caplin Point Laboratories re-appointed Dr. Sridhar Ganesan as Managing Director and appointed Mr. D. Muralidharan as Whole-Time Director. Both appointments are for two-year terms.

Source

NSE filing, NSE: CAPLIPOINT. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Caplin Point Laboratories Ltd: key numbers

Share price
₹2,381.70
Market cap
₹18,104 Cr
Revenue (annual)
₹2,187 Cr
Net profit (annual)
₹641.2 Cr
P/E (TTM)
27.2×Sector 42.0×
Promoter holding
70.57%+0.00% QoQ
FII holding
5.72%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Caplin Point Laboratories Ltd

All →

Other management change announcements

All →